John Robert Vane
573 works · 80,278 citations · h-index 126
Top works
- Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like Drugs
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation
- Release of Additional Factors in Anaphylaxis and its Antagonism by Anti-inflammatory Drugs
- A SENSITIVE METHOD FOR THE ASSAY OF 5‐HYDROXYTRYPTAMINE
- Prostaglandins released by the Spleen
- THE USE OF ISOLATED ORGANS FOR DETECTING ACTIVE SUBSTANCES IN THE CIRCULATING BLOOD
- Prostaglandins: Their Disappearance from and Release into the Circulation
- Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides
- Indomethacin and Aspirin abolish Prostaglandin Release from the Spleen
- Arachidonic Acid Metabolites and the Interactions between Platelets and Blood-Vessel Walls
- The chemical structure of prostaglandin X (prostacyclin)
- Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac arteries and inhibits platelet aggregation
- HUMAN ARTERIAL AND VENOUS TISSUES GENERATE PROSTACYCLIN (PROSTAGLANDIN X), A POTENT INHIBITOR OF PLATELET AGGREGATION
- Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase.
- A lipid peroxide inhibits the enzyme in blood vessel microsomes that generates from prostaglandin endoperoxides the substance (prostaglandin X) which prevents platelet aggregation
- Regulatory Functions of the Vascular Endothelium
- A SENSITIVE METHOD FOR THE ASSAY OF ANGIOTENSIN
- The release and fate of vaso‐active hormones in the circulation
- Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin.
- Conversion of Angiotensin I to Angiotensin II